Literature DB >> 26731335

Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat: Historical perspective.

Dianne P Figlewicz1.   

Abstract

UNLABELLED: Since the publication of the observation that dopaminergic neurons in the ventral tegmental area/substantia nigra of the rat express receptors for insulin and leptin, numerous studies have extended and validated these findings. Thus, these major metabolic hormones have effects on synaptic and cell signaling function of the midbrain dopamine neurons, across a range of concentrations that reflect physiologic (fasting vs. fed) and pathophysiologic (diabetes) circumstances. The capacity of metabolic hormones to alter reward behaviors, including palatability-related food intake; motivation for food; and the conditioning of place preference by food, is now appreciated as an integral part of the larger actions of these hormones to regulate caloric homeostasis. Finally, the delineation of metabolic hormone effects on the CNS reward circuitry of normal animals provides the rationale and experimental basis for evaluating dysfunction of reward circuitry in obesity and diabetes. ORIGINAL ARTICLE ABSTRACT: EXPRESSION OF RECEPTORS FOR INSULIN AND LEPTIN IN THE VENTRAL TEGMENTAL AREA/SUBSTANTIA NIGRA (VTA/SN) OF THE RAT: Recent studies have demonstrated that the metabolic hormones insulin and leptin can modulate behavioral performance in reward-related paradigms. However, specific anatomical substrate(s) within the CNS for these effects remain to be identified. We hypothesize that midbrain dopamine neurons, which have been implicated to be critical in the mediation of motivational and reward aspects of stimuli, contribute to these behavioral effects of insulin and leptin. As one approach to evaluate this hypothesis, we used double-labeling fluorescence immunohistochemistry to determine whether the midbrain dopamine neurons express insulin receptors or leptin receptors. Extensive co-expression of tyrosine hydroxylase (a marker for dopamine neurons) with both the insulin receptor and the leptin receptor was observed in the ventral tegmentum and substantia nigra. These findings suggest that midbrain dopamine neurons are direct targets of insulin and leptin, and that they participate in mediating the effects of these hormones on reward-seeking behavior. This article is part of a Special Issue entitled SI:50th Anniversary Issue. Published by Elsevier B.V.

Entities:  

Keywords:  Dopamine; Fluorescence immunocytochemistry; Ingestive behavior; Reward

Mesh:

Substances:

Year:  2015        PMID: 26731335     DOI: 10.1016/j.brainres.2015.12.041

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Two distinct GUCY2C circuits with PMV (hypothalamic) and SN/VTA (midbrain) origin.

Authors:  D J Merlino; J R Barton; B A Charsar; M D Byrne; J A Rappaport; R J Smeyne; A C Lepore; A E Snook; S A Waldman
Journal:  Brain Struct Funct       Date:  2019-09-04       Impact factor: 3.270

2.  Brain and behavioral correlates of insulin resistance in youth with depression and obesity.

Authors:  Manpreet K Singh; Sara M Leslie; Mary Melissa Packer; Yevgeniya V Zaiko; Owen R Phillips; Elizabeth F Weisman; Danielle M Wall; Booil Jo; Natalie Rasgon
Journal:  Horm Behav       Date:  2018-04-23       Impact factor: 3.587

3.  Electroacupuncture enhances resting-state functional connectivity between dorsal caudate and precuneus and decreases associated leptin levels in overweight/obese subjects.

Authors:  Yang He; Karen M von Deneen; Guanya Li; Borong Jing; Yanyan Zhou; Kaiya Zhang; Yi Zhang; Yuanyuan Ren
Journal:  Brain Imaging Behav       Date:  2021-08-20       Impact factor: 3.978

Review 4.  Crosstalk between neurological, cardiovascular, and lifestyle disorders: insulin and lipoproteins in the lead role.

Authors:  Richa Tyagi; Bhupesh Vaidya; Shyam Sunder Sharma
Journal:  Pharmacol Rep       Date:  2022-09-23       Impact factor: 3.919

Review 5.  Satiety Associated with Calorie Restriction and Time-Restricted Feeding: Central Neuroendocrine Integration.

Authors:  Debra K M Tacad; Ashley P Tovar; Christine E Richardson; William F Horn; Nancy L Keim; Giri P Krishnan; Sridevi Krishnan
Journal:  Adv Nutr       Date:  2022-06-01       Impact factor: 11.567

Review 6.  Role of astrocytes, microglia, and tanycytes in brain control of systemic metabolism.

Authors:  Cristina García-Cáceres; Eglantine Balland; Vincent Prevot; Serge Luquet; Stephen C Woods; Marco Koch; Tamas L Horvath; Chun-Xia Yi; Julia A Chowen; Alexei Verkhratsky; Alfonso Araque; Ingo Bechmann; Matthias H Tschöp
Journal:  Nat Neurosci       Date:  2018-12-10       Impact factor: 24.884

Review 7.  Gut-Brain Cross-Talk in Metabolic Control.

Authors:  Christoffer Clemmensen; Timo D Müller; Stephen C Woods; Hans-Rudolf Berthoud; Randy J Seeley; Matthias H Tschöp
Journal:  Cell       Date:  2017-02-23       Impact factor: 41.582

8.  Selective serotonin receptor stimulation of the ventral tegmentum differentially affects appetitive motivation for sugar on a progressive ratio schedule of reinforcement.

Authors:  Wayne E Pratt; Rafaella Vaca-Tricerri; Alexa C Blanchard; Thomas R Hopkins; Adeolu O Ilesanmi; Zachary Pierce-Messick; Ian A Rosner; Rose Ying
Journal:  Behav Brain Res       Date:  2021-01-23       Impact factor: 3.332

Review 9.  Obesity - A Matter of Motivation?

Authors:  Ruth Hanssen; Sharmili E Thanarajah; Marc Tittgemeyer; Jens C Brüning
Journal:  Exp Clin Endocrinol Diabetes       Date:  2022-02-18       Impact factor: 2.426

10.  A biologically-informed polygenic score identifies endophenotypes and clinical conditions associated with the insulin receptor function on specific brain regions.

Authors:  Shantala A Hari Dass; Kathryn McCracken; Irina Pokhvisneva; Lawrence M Chen; Elika Garg; Thao T T Nguyen; Zihan Wang; Barbara Barth; Moein Yaqubi; Lisa M McEwen; Julie L MacIsaac; Josie Diorio; Michael S Kobor; Kieran J O'Donnell; Michael J Meaney; Patricia P Silveira
Journal:  EBioMedicine       Date:  2019-03-26       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.